AeroClean Technologies, Inc.

AeroClean Technologies, Inc. (AERC), relating to its proposed merger with Molekule, Inc. Under the terms of the agreement, AERC shareholders will own approximately 50.5% of the outstanding common equity of the combined company.

Poshmark, Inc.

Poshmark, Inc. (POSH), relating to its proposed acquisition by NAVER Corp. Under the terms of the agreement, POSH shareholders will receive $17.90 in cash per share they own

BTRS Holdings Inc.

BTRS Holdings Inc. (BTRS), relating to its proposed acquisition by EQT X fund. Under the terms of the agreement, BTRS shareholders will receive $9.50 in cash per share they own.

LogicBio Therapeutics, Inc

LogicBio Therapeutics, Inc. (LOGC), relating to its proposed acquisition by AstraZeneca Rare Disease. Under the terms of the tender offer, LOGC shareholders will receive $2.07 in cash per share they own.

Talos Energy Inc.

Talos Energy Inc. (TALO), relating to its proposed merger with EnVen Energy Corp.

CarLotz, Inc.

CarLotz, Inc. (LOTZ), relating to its proposed merger with Shift Technologies, Inc. Under the terms of the agreement, LOTZ shareholders are expected to receive 0.692158 shares of Shift per share they own, with LOTZ shareholders owning approximately 47.1% of the combined company.

Stonemor, Inc.

Stonemor, Inc. (STON), relating to its proposed acquisition by a subsidiary of Axar Capital Management, LP. Under the terms of the agreement, STON shareholders will receive $3.50 in cash per share they own.

Renovacor, Inc.

Renovacor, Inc. (RCOR), relating to its proposed acquisition by Rocket Pharmaceuticals, Inc. Under the terms of the agreement, RCOR shareholders will receive 0.1676 shares of Rocket per share they own.

Southern Missouri Bancorp, Inc.

Southern Missouri Bancorp, Inc. (SMBC), relating to its proposed merger with Citizens Bancshares Co. Under the terms of the agreement, Citizens shareholders will receive either 1.1448 shares of SMBC common stock or $53.50 in cash per share they own

Ra Medical Systems, Inc.

Ra Medical Systems, Inc. (RMED), relating to its proposed merger with Catheter Precision, Inc. Under the terms of the agreement, RMED shareholders are expected to own approximately 20% of the combined company